{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:13:39Z","timestamp":1786662819827,"version":"build-2736575974"},"reference-count":175,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medizinische Universit\u00e4t Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>The development of small-molecule calcitonin gene-related peptide (CGRP) receptor antagonists (gepants) and of monoclonal antibodies targeting the CGRP system has been a major advance in the management of migraine. In the randomized controlled trials before regulatory approval, the safety of these anti-CGRP migraine therapeutics was considered favorable and to stay within the expected profile. Post-approval real-world surveys reveal, however, constipation to be a major adverse event which may affect more than 50% of patients treated with erenumab (an antibody targeting the CGRP receptor), fremanezumab or galcanezumab (antibodies targeting CGRP). In this review article we address the question whether constipation caused by inhibition of CGRP signaling can be mechanistically deduced from the known pharmacological actions and pathophysiological implications of CGRP in the digestive tract. CGRP in the gut is expressed by two distinct neuronal populations: extrinsic primary afferent nerve fibers and distinct neurons of the intrinsic enteric nervous system. In particular, CGRP is a major messenger of enteric sensory neurons which in response to mucosal stimulation activate both ascending excitatory and descending inhibitory neuronal pathways that enable propulsive (peristaltic) motor activity to take place. In addition, CGRP is able to stimulate ion and water secretion into the intestinal lumen. The motor-stimulating and prosecretory actions of CGRP combine in accelerating intestinal transit, an activity profile that has been confirmed by the ability of CGRP to induce diarrhea in mice, dogs and humans. We therefore conclude that the constipation elicited by antibodies targeting CGRP or its receptor results from interference with the physiological function of CGRP in the small and large intestine in which it contributes to the maintenance of peristaltic motor activity, ion and water secretion and intestinal transit.<\/jats:p>","DOI":"10.3389\/fphys.2021.820006","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T04:51:09Z","timestamp":1641876669000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":67,"title":["Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide\u2019s Motor-Stimulating and Prosecretory Function in the Intestine"],"prefix":"10.3389","volume":"12","author":[{"given":"Peter","family":"Holzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Holzer-Petsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1468-2982.2007.01486.x","article-title":"Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study.","volume":"28","author":"Aamodt","year":"2008","journal-title":"Cephalalgia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1056\/NEJMoa2035908","article-title":"Atogepant for the preventive treatment of migraine.","volume":"385","author":"Ailani","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/head.13682","article-title":"Long-term safety evaluation of ubrogepant for the acute treatment of migraine: phase 3, randomized, 52-week extension trial.","volume":"60","author":"Ailani","year":"2020","journal-title":"Headache"},{"key":"B4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF03326432","article-title":"Acid-sensing pathways in rat gastrointestinal mucosa.","volume":"37","author":"Akiba","year":"2002","journal-title":"J. Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2012.09.055","article-title":"The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice.","volume":"144","author":"Alemi","year":"2013","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/head.13956","article-title":"Safety and tolerability of 3 CGRP monoclonal antibodies in practice: a retrospective cohort study.","volume":"60","author":"Alex","year":"2020","journal-title":"Headache"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01136-z","article-title":"Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study.","volume":"21","author":"Ashina","year":"2020","journal-title":"J. Headache Pain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0333102420905132","article-title":"Eptinezumab in episodic migraine: a randomized, double-blind, placebo-controlled study (PROMISE-1).","volume":"40","author":"Ashina","year":"2020","journal-title":"Cephalalgia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF02090208","article-title":"Effect of vagotomy on expression of neuropeptides and histamine in rat oxyntic mucosa.","volume":"39","author":"B\u00e4ck","year":"1994","journal-title":"Digest. Dis. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/BF00168922","article-title":"The inhibitory modulation of guinea-pig intestinal peristalsis caused by capsaicin involves calcitonin gene-related peptide and nitric oxide.","volume":"353","author":"Barth\u00f3","year":"1995","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0304-3940(91)90744-e","article-title":"Antagonism of the effects of calcitonin gene-related peptide and of capsaicin on the guinea-pig isolated ileum by human alpha-calcitonin gene-related peptide(8-37).","volume":"129","author":"Barth\u00f3","year":"1991","journal-title":"Neurosci. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/CEG.S256364","article-title":"Chronic idiopathic constipation in adults: a review on current guidelines and emerging treatment options.","volume":"14","author":"Bassotti","year":"2021","journal-title":"Clin. Exp. Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01267-x","article-title":"MAB-MIG: registry of the Spanish Neurological Society of erenumab for migraine prevention.","volume":"22","author":"Belv\u00eds","year":"2021","journal-title":"J. Headache Pain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/0333102420983282","article-title":"Migraine therapeutics differentially modulate the CGRP pathway.","volume":"41","author":"Bhakta","year":"2021","journal-title":"Cephalalgia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1073\/pnas.1219733110","article-title":"Local injection of dsRNA targeting calcitonin receptor-like receptor (CLR) ameliorates Clostridium difficile toxin A-induced ileitis.","volume":"110","author":"Bhargava","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.autneu.2004.03.005","article-title":"Immunohistochemical characterization of putative primary afferent (sensory) myenteric neurons in human small intestine.","volume":"112","author":"Brehmer","year":"2004","journal-title":"Auton. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.10358","article-title":"Correlated morphological and chemical phenotyping in myenteric type V neurons of porcine ileum.","volume":"453","author":"Brehmer","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1193-2","article-title":"A phase 3, long-term, open-label safety study of galcanezumab in patients with migraine.","volume":"18","author":"Camporeale","year":"2018","journal-title":"BMC Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/nmo.12825","article-title":"Sensory innervation of the guinea pig colon and rectum compared using retrograde tracing and immunohistochemistry.","volume":"28","author":"Chen","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"key":"B20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/head.14062","article-title":"Real-world efficacy, tolerability, and safety of ubrogepant.","volume":"61","author":"Chiang","year":"2021","journal-title":"Headache"},{"key":"B21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/0333102420914913","article-title":"No central action of CGRP antagonising drugs in the GTN mouse model of migraine.","volume":"40","author":"Christensen","year":"2020","journal-title":"Cephalalgia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"G36","DOI":"10.1152\/ajpgi.00464.2006","article-title":"Role of calcitonin receptor-like receptor in colonic motility and inflammation.","volume":"293","author":"Clifton","year":"2007","journal-title":"Am. J. Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.peptides.2012.03.020","article-title":"Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract.","volume":"35","author":"Cottrell","year":"2012","journal-title":"Peptides"},{"key":"B24","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1139\/y95-135","article-title":"Receptors for calcitonin gene related peptide (CGRP) in gastrointestinal epithelia.","volume":"73","author":"Cox","year":"1995","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/j.1476-5381.1994.tb17131.x","article-title":"Calcitonin gene-related peptide receptors in human gastrointestinal epithelia.","volume":"113","author":"Cox","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","article-title":"Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.","volume":"394","author":"Croop","year":"2019","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/mi.2014.82","article-title":"TRPM8 on mucosal sensory nerves regulates colitogenic responses by innate immune cells via CGRP.","volume":"8","author":"de Jong","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1111\/ene.15075","article-title":"Treatment with the monoclonal calcitonin gene-related peptide receptor antibody erenumab: a real-life study.","volume":"28","author":"de Vries Lentsch","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejphar.2009.04.055","article-title":"Involvement of afferent neurons in the pathogenesis of endotoxin-induced ileus in mice: role of CGRP and TRPV1 receptors.","volume":"615","author":"De Winter","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0807-1","article-title":"Blocking CGRP in migraine patients - a review of pros and cons.","volume":"18","author":"Deen","year":"2017","journal-title":"J. Headache Pain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/14740338.2021.1933941","article-title":"Safety and tolerability evaluation of erenumab for the preventive treatment of migraine.","volume":"20","author":"Deligianni","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e2211","DOI":"10.1212\/WNL.0000000000006640","article-title":"Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study.","volume":"91","author":"Detke","year":"2018","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1177\/0333102418759786","article-title":"A Phase 3 randomized trial of erenumab for episodic migraine.","volume":"38","author":"Dodick","year":"","journal-title":"Cephalalgia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1001\/jama.2018.4853","article-title":"Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial.","volume":"319","author":"Dodick","year":"","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the treatment of migraine.","volume":"381","author":"Dodick","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00303272","article-title":"Slow transit chronic constipation (Arbuthnot Lane\u2019s disease). An immunohistochemical study of neuropeptide-containing nerves in resected specimens from the large bowel.","volume":"5","author":"Dolk","year":"1990","journal-title":"Int. J. Colorectal Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/164_2018_201","article-title":"Role of CGRP in migraine.","volume":"255","author":"Edvinsson","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s40261-021-01059-w","article-title":"Real-life response to erenumab in a therapy-resistant case series of migraine patients from the province of Quebec, Eastern Canada.","volume":"41","author":"Eghtesadi","year":"2021","journal-title":"Clin. Drug Investig."},{"key":"B39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0306-4522(87)90010-8","article-title":"Projections of peptide-containing neurons in rat small intestine.","volume":"20","author":"Ekblad","year":"1987","journal-title":"Neuroscience"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1053\/j.gastro.2011.07.002","article-title":"TRPA1 and substance P mediate colitis in mice.","volume":"141","author":"Engel","year":"2011","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1096\/fj.14.10.1439","article-title":"A novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitis.","volume":"14","author":"Esfandyari","year":"2000","journal-title":"FASEB J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0928-4257(93)90017-n","article-title":"Involvement of calcitonin gene-related peptide in rat experimental colitis.","volume":"87","author":"Evangelista","year":"1993","journal-title":"J. Physiol. Paris"},{"key":"B43","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/head.13795","article-title":"Two-hour CGRP infusion causes gastrointestinal hyperactivity: possible relevance for CGRP antibody treatment.","volume":"60","author":"Falkenberg","year":"2020","journal-title":"Headache"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2050640618818305","article-title":"Pathophysiology and management of opioid-induced constipation: European expert consensus statement.","volume":"7","author":"Farmer","year":"2019","journal-title":"United Eur. Gastroenterol. J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40120-021-00245-4","article-title":"Real-world treatment profiles, clinical outcomes, and healthcare resource utilization of patients with migraine prescribed erenumab: a multicenter chart-review study of US Headache Centers.","volume":"10","author":"Faust","year":"2021","journal-title":"Neurol. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(19)31946-4","article-title":"Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.","volume":"394","author":"Ferrari","year":"2019","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3940(91)90324-m","article-title":"Immunoneutralization suggests that calcitonin gene related peptide regulates gastric emptying in the rat.","volume":"131","author":"Forster","year":"1991","journal-title":"Neurosci. Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/gast.1996.v111.pm8898642","article-title":"Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine.","volume":"111","author":"Foxx-Orenstein","year":"1996","journal-title":"Gastroenterology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/s1091-255x(99)80006-7","article-title":"Role of alpha- and beta-calcitonin gene-related peptide in postoperative small bowel ileus.","volume":"3","author":"Freeman","year":"1999","journal-title":"J. Gastrointest. Surg."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s00134-004-2317-2","article-title":"Differential reversal of drug-induced small bowel paralysis by cerulein and neostigmine.","volume":"30","author":"Fruhwald","year":"2004","journal-title":"Intensive Care Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00214637","article-title":"Neurochemically similar myenteric and submucous neurons directly traced to the mucosa of the small intestine.","volume":"241","author":"Furness","year":"1985","journal-title":"Cell Tissue Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-004-0895-5","article-title":"Projections and chemistry of Dogiel type II neurons in the mouse colon.","volume":"317","author":"Furness","year":"2004","journal-title":"Cell Tissue Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/0306-4522(89)90439-9","article-title":"Calcitonin gene-related peptide-\u03b1 receptor binding sites in the gastrointestinal tract.","volume":"31","author":"Gates","year":"1989","journal-title":"Neuroscience"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/nmo.12584","article-title":"The novel CGRP receptor antagonist BIBN4096BS alleviates a postoperative intestinal inflammation and prevents postoperative ileus.","volume":"27","author":"Glowka","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMoa1705848","article-title":"A controlled trial of erenumab for episodic migraine.","volume":"377","author":"Goadsby","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1212\/WNL.0000000000010019","article-title":"One-year sustained efficacy of erenumab in episodic migraine: results of the STRIVE study.","volume":"95","author":"Goadsby","year":"2020","journal-title":"Neurology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0306-4522(88)90017-6","article-title":"Characterization of the peptidergic afferent innervation of the stomach in the rat, mouse and guinea-pig.","volume":"25","author":"Green","year":"1988","journal-title":"Neuroscience"},{"key":"B58","doi-asserted-by":"publisher","first-page":"G1139","DOI":"10.1152\/ajpgi.1994.266.6.G1139","article-title":"CGRP as a transmitter in the sensory pathway mediating peristaltic reflex.","volume":"266","author":"Grider","year":"1994","journal-title":"Am. J. Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1124\/jpet.103.053512","article-title":"Neurotransmitters mediating the intestinal peristaltic reflex in the mouse.","volume":"307","author":"Grider","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/s0016-5085(98)70203-3","article-title":"5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine.","volume":"115","author":"Grider","year":"1998","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01097-3","article-title":"Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies.","volume":"21","author":"Haanes","year":"2020","journal-title":"J. Headache Pain"},{"key":"B62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00441-002-0616-x","article-title":"Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues.","volume":"310","author":"Hagner","year":"2002","journal-title":"Cell Tissue Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1677\/joe.0.1520275","article-title":"Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.","volume":"152","author":"Hanna","year":"1997","journal-title":"J. Endocrinol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/head.13510","article-title":"Calcitonin gene-related peptide modulators - the history and renaissance of a new migraine drug class.","volume":"59","author":"Hargreaves","year":"2019","journal-title":"Headache"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.14075","article-title":"Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25.","volume":"175","author":"Hay","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clnu.2007.08.001","article-title":"Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients - current status and future options.","volume":"27","author":"Herbert","year":"2008","journal-title":"Clin. Nutr."},{"key":"B67","doi-asserted-by":"publisher","first-page":"G53","DOI":"10.1152\/ajpgi.00234.2017","article-title":"Synaptic activation of putative sensory neurons by hexamethonium-sensitive nerve pathways in mouse colon.","volume":"314","author":"Hibberd","year":"2018","journal-title":"Am. J. Physiol."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01313-8","article-title":"Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial.","volume":"22","author":"Hirata","year":"2021","journal-title":"J. Headache Pain"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(08)61626-8","article-title":"Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.","volume":"372","author":"Ho","year":"2008","journal-title":"Lancet"},{"key":"B70","first-page":"493","article-title":"\u201cCalcitonin gene-related peptide,\u201d in","author":"Holzer","year":"1994","journal-title":"Gut Peptides: Biochemistry and Physiology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s0016-5085(98)70597-9","article-title":"Neural emergency system in the stomach.","volume":"114","author":"Holzer","year":"1998","journal-title":"Gastroenterology"},{"key":"B72","first-page":"125","article-title":"\u201cCalcitonin gene-related peptide in gastrointestinal homeostasis,\u201d in","author":"Holzer","year":"2000","journal-title":"The CGRP Family: Calcitonin Gene-Related Peptide (CGRP), Amylin, and Adrenomedullin"},{"key":"B73","doi-asserted-by":"publisher","first-page":"G546","DOI":"10.1152\/ajpgi.1989.256.3.G546","article-title":"Calcitonin gene-related peptide action on intestinal circular muscle.","volume":"256","author":"Holzer","year":"1989","journal-title":"Am. J. Physiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/head.14095","article-title":"Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: a randomized phase 1b drug-drug interaction study.","volume":"61","author":"Jakate","year":"2021","journal-title":"Headache"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1177\/0333102419844711","article-title":"Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I]galcanezumab in male rats.","volume":"39","author":"Johnson","year":"2019","journal-title":"Cephalalgia"},{"key":"B76","doi-asserted-by":"publisher","first-page":"G141","DOI":"10.1152\/ajpgi.1997.272.1.G141","article-title":"Tachykininergic mediation of viscerosensitive responses to acute inflammation in rats: role of CGRP.","volume":"272","author":"Julia","year":"1997","journal-title":"Am. J. Physiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.npep.2016.11.004","article-title":"Anti-CGRP antibodies block CGRP-induced diarrhea in mice.","volume":"64","author":"Kaiser","year":"2017","journal-title":"Neuropeptides"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1177\/0333102420946725","article-title":"Real-world effectiveness and tolerability of erenumab: a retrospective cohort study.","volume":"40","author":"Kanaan","year":"2020","journal-title":"Cephalalgia"},{"key":"B79","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/jgh.13505","article-title":"RAMP1 suppresses mucosal injury from dextran sodium sulfate-induced colitis in mice.","volume":"32","author":"Kawashima-Takeda","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"G196","DOI":"10.1152\/ajpgi.1998.274.1.G196","article-title":"CGRP upregulation in dorsal root ganglia and ileal mucosa during Clostridium difficile toxin A-induced enteritis.","volume":"274","author":"Keates","year":"1998","journal-title":"Am. J. Physiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1526-4610.2004.04168.x","article-title":"The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs.","volume":"44","author":"Kelman","year":"2004","journal-title":"Headache"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/j.1476-5381.1995.tb15038.x","article-title":"Calcitonin gene-related peptide (CGRP)-enhanced non-adrenergic non-cholinergic contraction of guinea-pig proximal colon.","volume":"115","author":"Kojima","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02123-w","article-title":"Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial.","volume":"21","author":"Kudrow","year":"2021","journal-title":"BMC Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders.","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01127-0","article-title":"A prospective real-world analysis of erenumab in refractory chronic migraine.","volume":"21","author":"Lambru","year":"2020","journal-title":"J. Headache Pain"},{"key":"B86","doi-asserted-by":"publisher","first-page":"G920","DOI":"10.1152\/ajpgi.1988.254.6.G920","article-title":"Calcitonin and CGRP inhibit gastrointestinal transit via distinct neuronal pathways.","volume":"254","author":"Lenz","year":"1988","journal-title":"Am. J. Physiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s0196-9781(00)00160-1","article-title":"Digestive motor effects and vascular actions of CGRP in dog are expressed by different receptor subtypes.","volume":"21","author":"L\u2019Heureux","year":"2000","journal-title":"Peptides"},{"key":"B88","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1811090","article-title":"Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine.","volume":"381","author":"Lipton","year":"","journal-title":"N. Engl. J. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1001\/jama.2019.16711","article-title":"Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial.","volume":"322","author":"Lipton","year":"","journal-title":"JAMA"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e1365","DOI":"10.1212\/WNL.0000000000009169","article-title":"Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.","volume":"94","author":"Lipton","year":"2020","journal-title":"Neurology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.tips.2016.06.002","article-title":"Wiping out CGRP: potential cardiovascular risks.","volume":"37","author":"MaassenVanDenBrink","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0301-0082(94)e0017-b","article-title":"Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves.","volume":"45","author":"Maggi","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0167-0115(97)00006-2","article-title":"CGRP potentiates excitatory transmission to the circular muscle of guinea-pig colon.","volume":"69","author":"Maggi","year":"1997","journal-title":"Regul. Pept."},{"key":"B94","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0167-0115(95)00133-6","article-title":"Calcitonin gene-related peptide (CGRP) in the circular muscle of guinea-pig colon: role as inhibitory transmitter and mechanisms of relaxation.","volume":"61","author":"Maggi","year":"1996","journal-title":"Regul. Pept."},{"key":"B95","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/BF00169740","article-title":"Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides.","volume":"341","author":"Maggi","year":"1990","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/s0196-9781(99)00144-8","article-title":"Vagally dependent protective action of calcitonin gene-related peptide on colitis.","volume":"20","author":"Mazelin","year":"1999","journal-title":"Peptides"},{"key":"B97","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0167-0115(89)90214-0","article-title":"Human \u03b1-calcitonin gene-related peptide influences colonic secretion by acting on myenteric neurons.","volume":"24","author":"McCulloch","year":"1989","journal-title":"Regul. Pept."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1177\/0333102418786261","article-title":"Current understanding of trigeminal ganglion structure and function in headache.","volume":"39","author":"Messlinger","year":"2019","journal-title":"Cephalalgia"},{"key":"B99","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00441-009-0798-6","article-title":"Characterisation of calcitonin gene-related peptide-immunoreactive neurons in the myenteric plexus of rat colon.","volume":"337","author":"Mitsui","year":"2009","journal-title":"Cell Tissue Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00441-010-1080-7","article-title":"Immunohistochemical analysis of substance P-containing neurons in rat small intestine.","volume":"343","author":"Mitsui","year":"2011","journal-title":"Cell Tissue Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00441-009-0773-2","article-title":"Identification of neuron types in the submucosal ganglia of the mouse ileum.","volume":"336","author":"Mongardi Fantaguzzi","year":"2009","journal-title":"Cell Tissue Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/308746a0","article-title":"Isolation and characterization of human calcitonin gene-related peptide.","volume":"308","author":"Morris","year":"1984","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","article-title":"Differential expression of \u03b1-CGRP and \u00df-CGRP by primary sensory neurons and enteric autonomic neurons of the rat.","volume":"25","author":"Mulderry","year":"1988","journal-title":"Neuroscience"},{"key":"B104","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(20)30279-9","article-title":"Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.","volume":"19","author":"Mulleners","year":"2020","journal-title":"Lancet Neurol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/0333102419896760","article-title":"Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier.","volume":"40","author":"Noseda","year":"2020","journal-title":"Cephalalgia"},{"key":"B106","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/j.gastro.2007.10.001","article-title":"Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis.","volume":"134","author":"Ohno","year":"2008","journal-title":"Gastroenterology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa030505","article-title":"Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.","volume":"350","author":"Olesen","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13445","article-title":"Calcitonin gene-related peptide (CGRP) antagonists: a comprehensive review of safety, efficacy and prescribing information.","author":"Omaer","year":"2021","journal-title":"J. Clin Pharm. Ther."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01102-9","article-title":"Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy.","volume":"21","author":"Ornello","year":"2020","journal-title":"J. Headache Pain"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/s0196-9781(99)00142-4","article-title":"Specific calcitonin gene-related peptide binding sites present throughout rat intestine.","volume":"20","author":"Ozdemir","year":"1999","journal-title":"Peptides"},{"key":"B111","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0014-2999(86)90601-1","article-title":"Calcitonin gene-related peptide excites myenteric neurons.","volume":"132","author":"Palmer","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1523\/JNEUROSCI.20-09-03295.2000","article-title":"Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine.","volume":"20","author":"Pan","year":"2000","journal-title":"J. Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0014-2999(93)90645-X","article-title":"A monoclonal antibody to calcitonin gene-related peptide abolishes capsaicin-induced gastroprotection.","volume":"250","author":"Peskar","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/0196-9781(93)90180-o","article-title":"CGRP antagonists and capsaicin on celiac ganglia partly prevent postoperative gastric ileus.","volume":"14","author":"Plourde","year":"1993","journal-title":"Peptides"},{"key":"B115","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s13311-018-0622-7","article-title":"The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy.","volume":"15","author":"Raffaelli","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B116","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2796.1990.tb01486.x","article-title":"Influence on intestinal secretion of eicosanoids.","volume":"732","author":"Rask-Madsen","year":"1990","journal-title":"J. Intern. Med. Suppl."},{"key":"B117","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0167-0115(00)00242-1","article-title":"Localisation and neural control of the release of calcitonin gene-related peptide (CGRP) from the isolated perfused porcine ileum.","volume":"98","author":"Rasmussen","year":"2001","journal-title":"Regul. Pept."},{"key":"B118","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0196-9781(88)90114-3","article-title":"Central nervous system action of calcitonin gene-related peptide to inhibit gastric emptying in the conscious rat.","volume":"9","author":"Raybould","year":"1988","journal-title":"Peptides"},{"key":"B119","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/0016-5085(88)90170-9","article-title":"Calcitonin gene-related peptide: enteric and cardiovascular effects in the dog.","volume":"95","author":"Reasbeck","year":"1988","journal-title":"Gastroenterology"},{"key":"B120","first-page":"657","article-title":"Calcitonin gene-related peptide mediates the protective effect of sensory nerves in a model of colonic injury.","volume":"286","author":"Reinshagen","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/s0196-9781(97)00246-5","article-title":"The calcitonin gene-related peptide activates both cAMP and NO pathways to induce relaxation of circular smooth muscle cells of guinea-pig ileum.","volume":"18","author":"Rekik","year":"1997","journal-title":"Peptides"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/S0140-6736(18)32534-0","article-title":"Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.","volume":"392","author":"Reuter","year":"2018","journal-title":"Lancet"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/head.13589","article-title":"Erenumab side effects.","volume":"59","author":"Robbins","year":"2019","journal-title":"Headache"},{"key":"B124","first-page":"48","article-title":"CGRP monoclonal antibodies for chronic migraine prevention: evaluation of adverse effects using a checklist.","volume":"20","author":"Robbins","year":"2020","journal-title":"Pract. Pain Manag."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/head.13951","article-title":"Real-world patient experience with erenumab for the preventive treatment of migraine.","volume":"60","author":"Robblee","year":"2020","journal-title":"Headache"},{"key":"B126","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1365-2982.2003.00456.x","article-title":"Characterization of the primary spinal afferent innervation of the mouse colon using retrograde labelling.","volume":"16","author":"Robinson","year":"2004","journal-title":"Neurogastroenterol. Motil."},{"key":"B127","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/BF01536340","article-title":"Intravenous calcitonin gene-related peptide stimulates net water secretion in rat colon in vivo.","volume":"34","author":"Rolston","year":"1989","journal-title":"Digest. Dis. Sci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/304129a0","article-title":"Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.","volume":"304","author":"Rosenfeld","year":"1983","journal-title":"Nature"},{"key":"B129","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0304-3959(01)00318-9","article-title":"Substance P, calcitonin gene related peptide and PGE2 co-released from the mouse colon: a new model to study nociceptive and inflammatory responses in viscera, in vitro.","volume":"93","author":"Roza","year":"2001","journal-title":"Pain"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology.","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01143-0","article-title":"Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience.","volume":"21","author":"Russo","year":"2020","journal-title":"J. Headache Pain"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/head.14178","article-title":"Efficacy and safety of fremanezumab for episodic migraine prevention: multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.","volume":"61","author":"Sakai","year":"2021","journal-title":"Headache"},{"key":"B133","doi-asserted-by":"publisher","first-page":"G789","DOI":"10.1152\/ajpgi.00451.2001","article-title":"Neuronal locus and cellular signaling for stimulation of ileal giant migrating and phasic contractions.","volume":"284","author":"Sarna","year":"2003","journal-title":"Am. J. Physiol."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01151-0","article-title":"Erenumab in highly therapy-refractory migraine patients: first German real-world evidence.","volume":"21","author":"Scheffler","year":"2020","journal-title":"J. Headache Pain"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01323-6","article-title":"CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience.","volume":"22","author":"Scheffler","year":"2021","journal-title":"J. Headache Pain"},{"key":"B136","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1365-2265.1986.tb03626.x","article-title":"Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma.","volume":"25","author":"Schifter","year":"1986","journal-title":"Clin. Endocrinol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/cne.20211","article-title":"Analysis of the cellular expression pattern of beta-CGRP in alpha-CGRP-deficient mice.","volume":"476","author":"Sch\u00fctz","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0167-0115(91)90068-r","article-title":"Calcitonin gene-related peptide (CGRP) modulates cholinergic neurotransmission in the small intestine of man, pig and guinea-pig via presynaptic CGRP receptors.","volume":"36","author":"Schw\u00f6rer","year":"1991","journal-title":"Regul. Pept."},{"key":"B139","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2265.1991.tb00310.x","article-title":"Production of calcitonin gene related peptide, calcitonin and PTH-related protein by a prostatic adenocarcinoma.","volume":"34","author":"Shulkes","year":"1991","journal-title":"Clin. Endocrinol."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01186-3","article-title":"Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.","volume":"21","author":"Silberstein","year":"2020","journal-title":"J. Headache Pain"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa1709038","article-title":"Fremanezumab for the preventive treatment of chronic migraine.","volume":"377","author":"Silberstein","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s40122-021-00273-w","article-title":"Effectiveness and safety of CGRP-mAbs in menstrual-related migraine: a real-world experience.","volume":"10","author":"Silvestro","year":"2021","journal-title":"Pain Ther."},{"key":"B143","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1365-2982.1997.d01-46.x","article-title":"Neuropeptides in idiopathic chronic constipation (slow transit constipation).","volume":"9","author":"Sj\u00f6lund","year":"1997","journal-title":"Neurogastroenterol. Motil."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1177\/0333102418779543","article-title":"Efficacy and safety of galcanezumab for the prevention of episodic migraine: results of the EVOLVE-2 Phase 3 randomized controlled clinical trial.","volume":"38","author":"Skljarevski","year":"2018","journal-title":"Cephalalgia"},{"key":"B145","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1440-1746.2005.03759.x","article-title":"Impaired capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease.","volume":"20","author":"Smith","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/cne.24872","article-title":"Intrinsic sensory neurons provide direct input to motor neurons and interneurons in mouse distal colon via varicose baskets.","volume":"528","author":"Smolilo","year":"2020","journal-title":"J. Comp. Neurol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2018.1212","article-title":"Evaluation of Galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial.","volume":"75","author":"Stauffer","year":"2018","journal-title":"JAMA Neurol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1749-6632.1992.tb22766.x","article-title":"Enteric and visceral afferent CGRP neurons. Targets of innervation and differential expression patterns.","volume":"657","author":"Sternini","year":"1992","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/08990229209144762","article-title":"Calcitonin gene-related peptide-containing neurons supplying the rat digestive system: differential distribution and expression pattern.","volume":"9","author":"Sternini","year":"1992","journal-title":"Somatosens. Mot. Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0167-0115(92)90020-u","article-title":"Calcitonin gene-related peptide neurons innervating the canine digestive system.","volume":"42","author":"Sternini","year":"1992","journal-title":"Regul. Pept."},{"key":"B151","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/0016-5085(87)90450-1","article-title":"Distribution and characterization of calcitonin gene-related peptide immunoreactivity in the digestive system of normal and capsaicin-treated rats.","volume":"93","author":"Sternini","year":"1987","journal-title":"Gastroenterology"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1523\/JNEUROSCI.07-09-02674.1987","article-title":"Dual intrinsic and extrinsic origins of CGRP- and NPY-immunoreactive nerves of rat gut and pancreas.","volume":"7","author":"Su","year":"1987","journal-title":"J. Neurosci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(16)00019-3","article-title":"Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.","volume":"15","author":"Sun","year":"2016","journal-title":"Lancet Neurol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0196-9781(94)00189-8","article-title":"Effects of calcitonin gene-related peptide on cyclic AMP production and relaxation of longitudinal muscle of guinea pig ileum.","volume":"16","author":"Sun","year":"1995","journal-title":"Peptides"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1023\/a:1018858208532","article-title":"Effects of several denervation procedures on distribution of calcitonin gene-related peptide and substance P immunoreactive fibers in rat stomach.","volume":"42","author":"Suzuki","year":"1997","journal-title":"Digest. Dis. Sci."},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12121180","article-title":"Pharmacokinetics, pharmacodynamics and drug-drug interactions of new anti-migraine drugs-lasmiditan, gepants, and calcitonin-gene-related peptide (CGRP) receptor monoclonal antibodies.","volume":"12","author":"Szkutnik-Fiedler","year":"2020","journal-title":"Pharmaceutics"},{"key":"B157","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-1-4899-0744-8_17","article-title":"Central and peripheral actions of calcitonin gene-related peptide on gastric secretory and motor function.","volume":"298","author":"Tach\u00e9","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jso.2930430108","article-title":"Calcitonin gene-related peptide in patients with endocrine tumors.","volume":"43","author":"Takami","year":"1990","journal-title":"J. Surg. Oncol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/head","article-title":"Erenumab treatment for migraine prevention in Japanese patients: efficacy and safety results from a phase 3, randomized, double-blind, placebo-controlled study.","volume":"61","author":"Takeshima","year":"2021","journal-title":"Headache"},{"key":"B160","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuroscience.2008.06.071","article-title":"Distinct chemical classes of medium-sized transient receptor potential channel vanilloid 1-immunoreactive dorsal root ganglion neurons innervate the adult mouse jejunum and colon.","volume":"156","author":"Tan","year":"2008","journal-title":"Neuroscience"},{"key":"B161","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/j.1365-2982.2009.01322.x","article-title":"Neurochemical and morphological phenotypes of vagal afferent neurons innervating the adult mouse jejunum.","volume":"21","author":"Tan","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"B162","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1474-4422(17)30083-2","article-title":"Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.","volume":"16","author":"Tepper","year":"2017","journal-title":"Lancet Neurol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10620-007-9848-7","article-title":"Protective roles of alpha-calcitonin and beta-calcitonin gene-related peptide in spontaneous and experimentally induced colitis.","volume":"53","author":"Thompson","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000147227","article-title":"Calcitonin gene-related peptide-like immunoreactivity in the human small intestine.","volume":"143","author":"Timmermans","year":"1992","journal-title":"Acta Anat."},{"key":"B165","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1007\/s00415-021-10523-8","article-title":"The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study.","volume":"268","author":"Torres-Ferr\u00fas","year":"2021","journal-title":"J. Neurol."},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13149","article-title":"Mucosal glucagon-like peptide 1 (GLP-1) responses are mediated by calcitonin gene-related peptide (CGRP) in the mouse colon and both peptide responses are area-specific.","volume":"30","author":"Tough","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"key":"B167","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/s0196-9781(03)00113-x","article-title":"Two new peptides to improve post-operative gastric ileus in dog.","volume":"24","author":"Trudel","year":"2003","journal-title":"Peptides"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s40265-021-01634-7","article-title":"Diarrhea-predominant and constipation-predominant irritable bowel syndrome: current prescription drug treatment options.","volume":"81","author":"Wechsler","year":"2021","journal-title":"Drugs"},{"key":"B169","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1001\/jama.2021.7665","article-title":"Effects of intravenous eptinezumab vs placebo on headache pain and most bothersome symptom when initiated during a migraine attack: a randomized clinical trial.","volume":"325","author":"Winner","year":"2021","journal-title":"JAMA"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/ar.20577","article-title":"Calcitonin gene-related peptide: a marker for putative primary afferent neurons in the pig small intestinal myenteric plexus?","volume":"290","author":"Wolf","year":"2007","journal-title":"Anat. Rec."},{"key":"B171","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/ibd\/izz303","article-title":"Leukocyte apheresis using a fiber filter suppresses colonic injury through calcitonin gene-related peptide induction.","volume":"26","author":"Yamasaki","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"B172","doi-asserted-by":"publisher","first-page":"12309","DOI":"10.1073\/pnas.1706656114","article-title":"Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission.","volume":"114","author":"Yarwood","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B173","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbrc.2011.05.141","article-title":"Suppression of ovalbumin-induced allergic diarrhea by diminished intestinal peristalsis in RAMP1-deficient mice.","volume":"410","author":"Yoshikawa","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B174","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1067\/msy.1998.88090","article-title":"Calcitonin gene-related peptide and spinal afferents partly mediate postoperative colonic ileus in the rat.","volume":"123","author":"Zittel","year":"1998","journal-title":"Surgery"},{"key":"B175","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000658-199401000-00013","article-title":"Role of spinal afferents and calcitonin gene-related peptide in the postoperative gastric ileus in anesthetized rats.","volume":"219","author":"Zittel","year":"1994","journal-title":"Ann. Surg."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.820006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T04:51:16Z","timestamp":1641876676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.820006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":175,"alternative-id":["10.3389\/fphys.2021.820006"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.820006","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"article-number":"820006"}}